Skip to content

News ticker

News Flash
New Hope for Liver Transplant Recipients: The Potential Life-Saving Role of GLP-1 Agonists

New Hope for Liver Transplant Recipients: The Potential Life-Saving Role of GLP-1 Agonists

on November 11, 2026
Posted by
The Future of Healing: CRI’s 2026 Gala Spotlights the "Next Is Now" Era of Immunotherapy

The Future of Healing: CRI’s 2026 Gala Spotlights the "Next Is Now" Era of Immunotherapy

on November 11, 2026
Posted by
Autumn Safety: A Comprehensive Guide to Protecting Older Adults During the Seasonal Transition

Autumn Safety: A Comprehensive Guide to Protecting Older Adults During the Seasonal Transition

on November 11, 2026
Posted by
Beyond the Cholesterol Horizon: New Proteomic Insights into Persistent Heart Disease Risk

Beyond the Cholesterol Horizon: New Proteomic Insights into Persistent Heart Disease Risk

on November 11, 2026
Posted by
Dismantling the Fortress: How Dr. Jennifer Guerriero is Redefining Cancer Immunotherapy

Dismantling the Fortress: How Dr. Jennifer Guerriero is Redefining Cancer Immunotherapy

on November 11, 2026
Posted by
The Future of Oncology: Could a Piece of Chewing Gum Combat Head and Neck Cancer?

The Future of Oncology: Could a Piece of Chewing Gum Combat Head and Neck Cancer?

on November 11, 2026
Posted by
Hanger and Numotion Forge North American Mobility Powerhouse in Landmark Merger

Hanger and Numotion Forge North American Mobility Powerhouse in Landmark Merger

on November 11, 2026
Posted by
Health Recovery Support
Health Recovery Support
Health Recovery Support
Health Recovery Support
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy
  • TOS

What are You Looking For?

Trending News

New Hope for Liver Transplant Recipients: The Potential Life-Saving Role of GLP-1 Agonists

New Hope for Liver Transplant Recipients: The Potential Life-Saving Role of GLP-1 Agonists

on November 11, 2026
Posted by
The Future of Healing: CRI’s 2026 Gala Spotlights the "Next Is Now" Era of Immunotherapy

The Future of Healing: CRI’s 2026 Gala Spotlights the "Next Is Now" Era of Immunotherapy

on November 11, 2026
Posted by
Autumn Safety: A Comprehensive Guide to Protecting Older Adults During the Seasonal Transition

Autumn Safety: A Comprehensive Guide to Protecting Older Adults During the Seasonal Transition

on November 11, 2026
Posted by
Beyond the Cholesterol Horizon: New Proteomic Insights into Persistent Heart Disease Risk

Beyond the Cholesterol Horizon: New Proteomic Insights into Persistent Heart Disease Risk

on November 11, 2026
Posted by
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy
  • TOS
© All rights reserved. Proudly powered by WordPress. Theme NewsCurve designed by WPInterface.
Tags
#zymeworks#zurimed#zurich#zumba#zuidgeest#zuffa
  • Home
  • targeting
  • Page 3

targeting

37 posts
Targeting the Root of Rheumatoid Arthritis: How Obakulactone Rewrites the Molecular Rules of Joint Inflammation
Posted in Fitness and Mobility

Targeting the Root of Rheumatoid Arthritis: How Obakulactone Rewrites the Molecular Rules of Joint Inflammation

on July 23, 2026
Bio-Engineered Breakthrough: UIC Researchers Uncover Tumor-Targeting Protein to "Starve" Cancer Cells
Posted in Cancer Recovery

Bio-Engineered Breakthrough: UIC Researchers Uncover Tumor-Targeting Protein to "Starve" Cancer Cells

on July 22, 2026
Breakthrough in Pancreatic Cancer Research: Targeting KRAS Mutations via Novel PCAI Compounds
Posted in Cancer Recovery

Breakthrough in Pancreatic Cancer Research: Targeting KRAS Mutations via Novel PCAI Compounds

on July 15, 2026
Nexalin Technology Secures Landmark Patent for Deep-Brain Neurostimulation, Targeting 2042 Market Dominance
Posted in Sleep Health

Nexalin Technology Secures Landmark Patent for Deep-Brain Neurostimulation, Targeting 2042 Market Dominance

on July 11, 2026
Targeting the Shield: Dr. Shelby Sloan’s Innovative Approach to Refractory Hodgkin’s Lymphoma
Posted in Cancer Recovery

Targeting the Shield: Dr. Shelby Sloan’s Innovative Approach to Refractory Hodgkin’s Lymphoma

on July 10, 2026
Targeting the "Tummy Roll" After 55: A Scientific Approach to Strength and Vitality
Posted in Nutrition and Recovery

Targeting the "Tummy Roll" After 55: A Scientific Approach to Strength and Vitality

on July 8, 2026
CMS Unveils Sweeping Medicare Overhaul: Targeting 340B Discounts and Site-Neutral Payments
Posted in Digital Health Tools

CMS Unveils Sweeping Medicare Overhaul: Targeting 340B Discounts and Site-Neutral Payments

on July 7, 2026
CMS Unveils Sweeping 2027 Outpatient Reform: Targeting 340B Discounts and Site-Neutral Payments
Posted in Digital Health Tools

CMS Unveils Sweeping 2027 Outpatient Reform: Targeting 340B Discounts and Site-Neutral Payments

on July 3, 2026
A Breakthrough in Joint Health: How Targeting ‘Gerozymes’ Could End the Need for Knee Replacements
Posted in Fitness and Mobility

A Breakthrough in Joint Health: How Targeting ‘Gerozymes’ Could End the Need for Knee Replacements

on June 28, 2026
Targeting the Root: Breakthrough Experimental Drug ION224 Offers New Hope for MASH Patients
Posted in Cancer Recovery

Targeting the Root: Breakthrough Experimental Drug ION224 Offers New Hope for MASH Patients

on June 24, 2026

Posts navigation

← Older Articles
Newer Articles →

Recent Posts

  • New Hope for Liver Transplant Recipients: The Potential Life-Saving Role of GLP-1 Agonists
  • The Future of Healing: CRI’s 2026 Gala Spotlights the "Next Is Now" Era of Immunotherapy
  • Autumn Safety: A Comprehensive Guide to Protecting Older Adults During the Seasonal Transition
  • Beyond the Cholesterol Horizon: New Proteomic Insights into Persistent Heart Disease Risk
  • Dismantling the Fortress: How Dr. Jennifer Guerriero is Redefining Cancer Immunotherapy

Recent Comments

No comments to show.
© All rights reserved. Proudly powered by WordPress. Theme NewsCurve designed by WPInterface.
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy
  • TOS